查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
结直肠癌筛查市场,通过筛查测试（粪便测试,结肠镜检查,CT结肠造影,柔性乙状结肠镜检查,其他）,用户,地区-大小,份额,前景,机会分析2022-2028
市场调查报告书
商品编码
1110146

结直肠癌筛查市场,通过筛查测试（粪便测试,结肠镜检查,CT结肠造影,柔性乙状结肠镜检查,其他）,用户,地区-大小,份额,前景,机会分析2022-2028

Colorectal Cancer Screening Market, By Screening Tests (Stool-based Tests, Colonoscopy, CT Colonography, Flexible Sigmoidoscopy, and Other Screening Tests), By End User, and By Geography - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028
出版日期: | 出版商: Coherent Market Insights | 英文 181 Pages | 商品交期: 2-3个工作天内

价格
简介目录

结直肠癌是一种在大肠（结肠）中形成的癌症。癌症也称为结肠癌或直肠癌，这取决于它从哪里开始。结直肠癌筛查很重要，因为如果及早发现结直肠癌是高度可治疗的。在结直肠癌的早期阶段，通常没有任何症状。定期筛查可降低结直肠癌死亡和并发症的风险。筛查有助于在症状出现之前及早发现癌症。如果在局部阶段诊断出癌症，存活率将达到 90%。如果癌症已经扩散到附近的组织、器官或区域淋巴结，5 年生存率为 73%。如果癌症扩散到远处，5年生存率为17%。

市场动态:

预计结直肠癌患病率的上升、癌症预防工作的加强以及公众对结直肠癌筛查的认识将有助于全球结直肠癌筛查市场在预测期内增长。是一些主要因素例如，结肠癌是一种致命的疾病，在没有积极筛查的情况下，它的早期阶段往往无法识别或未被诊断。筛查是检测结直肠癌的首要方法，并且几乎总是 100% 由大多数保险计划承保。 2021 年，美国政府宣布 3 月为“全国结直肠癌宣传月”，以提高对结直肠癌管理的认识，引起人们对结直肠癌这一美国第三大最常见癌症的关注。

本研究的主要特点

  • 本报告对全球结直肠癌筛查市场进行了深入分析，提供了以 2021 年为基准年的预测期（2022-2028 年）的市场规模和復合年增长率 (CAGR %)。
  • 它揭示了不同细分市场的潜在收入机会，并为该市场概述了一个有吸引力的投资建议矩阵。
  • 它还提供有关市场驱动因素、限制因素、机会、新产品发布或批准、市场趋势、区域前景、主要参与者采用的竞争策略等方面的重要见解。
  • 全球结直肠癌筛查市场主要参与者的概况基于以下参数，包括公司亮点、产品组合、关键亮点、业绩和战略。
  • 本研究涵盖的主要公司包括 Polymedco Inc.、Eiken Chemical Co. Ltd.、Sysmex Corporation、Siemens Healthineers、Quidel Corporation、Novigenix SA、Hemosure Inc.、Exact Sciences Corp.、Epigenomics Inc.、Olympus Corporation和临床基因组学技术私人有限公司等。
  • 本报告中的见解将使营销人员和企业高管能够就未来的产品发布、类型升级、市场扩张和营销策略做出明智的决策。
  • 全球结直肠癌筛查市场报告面向该行业的各种利益相关者，包括投资者、供应商、产品製造商、分销商、新进入者和财务分析师。
  • 利益相关者可以通过用于分析全球结直肠癌筛查市场的各种战略矩阵来促进决策制定。

第一章研究目标和先决条件

  • 调查目的
  • 先决条件
  • 缩写说明

第二章市场展望

  • 举报内容
    • 市场定义和范围
  • 执行摘要
    • 鼻给药模式市场:通过筛选测试
    • 鼻腔给药模式市场:按最终用户分类
    • 按地区分列的鼻腔给药模式市场
  • 连贯的机会图 (COM)

第 3 章市场动态、监管和趋势分析

  • 市场动态
    • 全球结直肠癌患病率不断上升
    • 筛选费用高
    • 有效筛查测试的出现
  • 影响分析
  • 主要亮点
  • 监管场景
  • 产品发布/批准
  • PEST 分析
  • PORTER 分析
  • 併购方案

第 4 章结直肠癌筛查市场 - 冠状病毒 (COVID-19) 大流行的影响

  • COVID-19 的流行病学
  • 供应方和需求方分析
  • 经济影响

第 5 章结直肠癌筛查市场，按筛查测试，2017-2028 年

  • 基于粪便的测试
  • 结肠镜检查
  • CT 结肠成像（虚拟结肠镜检查）
  • 柔性乙状结肠镜检查
  • 其他筛查测试

第 6 章结直肠癌筛查市场，按最终用户，2017-2028 年

  • 医院独立诊断实验室
  • 其他最终用户

第 7 章结直肠癌筛查市场 2017-2028 年各地区结直肠癌筛查市场

  • 北美
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东和非洲
  • 世界其他地区

第 8 章竞争格局

  • Polymedco Inc.
  • Eiken Chemical Co. Ltd.
  • Sysmex Corporation
  • Siemens Healthineers AG
  • Quidel Corporation
  • Novigenix SA
  • Hemosure Inc.
  • Exact Sciences Corp.
  • Epigenomics Inc.
  • Olympus Corporation
  • Clinical Genomics Technologies Pty Ltd.

第九章章节

  • 调查方法
  • 关于出版商
简介目录
Product Code: CMI5098

Colorectal cancer is a type of cancer that begins in the large intestine (colon). The cancer can also be called colon cancer or rectal cancer, depending on where they start. Colorectal cancer screening is important because when found early, colorectal cancer is highly treatable. Early stages of colorectal cancer usually present no symptoms. Regular screenings may reduce the risk for death and complications caused by colorectal cancer. Screening help find cancer at an early stage, before symptoms appear. If the cancer is diagnosed at a localized stage, the survival rate is 90%. If the cancer spread to surrounding tissues or organs and/or the regional lymph nodes, the 5-year survival rate is 73%. If the cancer has spread to distant parts of the body, the 5-year survival rate is 17%.

Market Dynamics:

Increasing prevalence of colorectal cancer, increasing cancer prevention initiatives, and rise in awareness among people about colorectal cancer screening are some major factors expected to aid in the growth of the global colorectal cancer screening market during the forecast period. For instance, colorectal cancer can be a deadly disease, but without proactive screenings, it's one that often goes unnoticed or undiagnosed in its early stages. Screenings are the No. 1 way to detect colorectal cancers and in most cases are covered 100% by most insurance plans. The US government, in 2021, declared March as the National Colorectal Cancer Awareness Month to increase awareness on colorectal cancer management, bringing attention to colorectal cancer, the third most commonly diagnosed cancer in the U.S.

Key features of the study:

  • This report provides in-depth analysis of the global colorectal cancer screening market, and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021 as the base year.
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global colorectal cancer screening market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include Polymedco Inc., Eiken Chemical Co. Ltd., Sysmex Corporation, Siemens Healthineers, Quidel Corporation, Novigenix SA, Hemosure Inc., Exact Sciences Corp., Epigenomics Inc., Olympus Corporation, and Clinical Genomics Technologies Pty Ltd., among others.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global colorectal cancer screening market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global colorectal cancer screening market.

Detailed Segmentation:

Global Colorectal Cancer Screening Market, By Screening Tests:

  • Stool-based Tests
  • Colonoscopy
  • CT Colonography (Virtual Colonoscopy)
  • Flexible Sigmoidoscopy
  • Other Screening Tests

Global Colorectal Cancer Screening Market, By End User:

  • Hospitals Independent Diagnostic Labs
  • Other End Users

Global Colorectal Cancer Screening Market, By Geography:

  • North America
  • South America
  • Europe
  • Asia-Pacific
  • Middle East & Africa

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Colorectal Cancer Screening, By Screening Tests
    • Market Colorectal Cancer Screening, By End User
    • Market Colorectal Cancer Screening, By Geography
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Increase in prevalence of colorectal cancer worldwide
    • High Screening Tests Costs
    • Advent of efficacious screening tests
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product launch/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Colorectal Cancer Screening Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Colorectal Cancer Screening Market, By Screening Tests, 2017-2028, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2022 and 2028 (%)
    • Y-o-Y Growth Analysis, 2017 - 2028
    • Segment Trends
  • Stool-based Tests
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
  • Colonoscopy
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
  • CT Colonography (Virtual Colonoscopy)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
  • Flexible Sigmoidoscopy
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
  • Other Screening Tests
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)

6. Colorectal Cancer Screening Market, By End User, 2017-2028, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2022 and 2028 (%)
    • Y-o-Y Growth Analysis, 2017 - 2028
    • Segment Trends
  • Hospitals Independent Diagnostic Labs
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
  • Other End Users
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)

7. Colorectal Cancer Screening Market, By Geography, 2017-2028, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2022 and 2028 (%)
    • Y-o-Y Growth Analysis, 2017 - 2028
    • Segment Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
  • Middle East and Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
  • Rest of World
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)

8. Competitive Landscape

  • Polymedco Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Eiken Chemical Co. Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Sysmex Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Siemens Healthineers AG
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Quidel Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Novigenix SA
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Hemosure Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Exact Sciences Corp.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Epigenomics Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Olympus Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Clinical Genomics Technologies Pty Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Analyst Views

9. Section

  • Research Methodology
  • About us